Form 8-K - Current report:
SEC Accession No. 0001079973-17-000220
Filing Date
2017-04-07
Accepted
2017-04-07 17:02:58
Documents
2
Period of Report
2017-04-06
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K bioptix_8k.htm 8-K 21152
2 EXHIBIT 10.1 ex10x1.htm EX-10.1 60055
  Complete submission text file 0001079973-17-000220.txt   82713
Mailing Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104
Business Address 834-F SOUTH PERRY STREET, SUITE 443 CASTLE ROCK CO 80104 303-794-2000
Bioptix, Inc. (Filer) CIK: 0001167419 (see all company filings)

EIN.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33675 | Film No.: 17750619
SIC: 2835 In Vitro & In Vivo Diagnostic Substances